Using artificial intelligence to improve lung cancer screening and risk prediction

Dr Ricardo Santos - President, Instituto ProPulmão
Using artificial intelligence to improve lung cancer screening and risk prediction ( Dr Ricardo Santos - President, Instituto ProPulmão )
6 Oct 2026

Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours

Dr Stefano Avanzini - Giannina Gaslini Institute, Genoa, Italy
Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours ( Dr Stefano Avanzini - Giannina Gaslini Institute, Genoa, Italy )
1 Oct 2026

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

Dr Kozo Kataoka - Hyogo Medical University, Nishinomiya, Japan
ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas ( Dr Kozo Kataoka - Hyogo Medical University, Nishinomiya, Japan )
6 Jul 2026

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina
ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer ( Dr Natalia Gandur - Instituto de Oncología 'Ángel H. Roffo', Buenos Aires, Argentina )
22 Jun 2026

CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia

Prof Carsten Niemann - Rigshospitalet, Copenhagen, Denmark
CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia ( Prof Carsten Niemann - Rigshospitalet, Copenhagen, Denmark )
18 Jun 2026

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy

Dr Minit Shah - Tata Memorial Centre, Mumbai, India
Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy ( Dr Minit Shah - Tata Memorial Centre, Mumbai, India )
17 Jun 2026

ASCO 2026: Comment: Multi-cancer earlier detection tests

Dr Marie Wood - UCHealth University of Colorado Hospital, Aurora, USA
ASCO 2026: Comment: Multi-cancer earlier detection tests ( Dr Marie Wood - UCHealth University of Colorado Hospital, Aurora, USA )
3 Jun 2026

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer

Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA
FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer ( Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA )
1 Jun 2026

ASCO 2026: Latest updates in mRCC

Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke
ASCO 2026: Latest updates in mRCC ( Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke )
30 May 2026

Part 1: Why test?

Dr Elena Castro - Hospital Universitario 12 de Octubre, Madrid, Spain
Part 1: Why test? ( Dr Elena Castro - Hospital Universitario 12 de Octubre, Madrid, Spain )
5 May 2026

Part 2: How to get biopsies for testing?

Dr Lynda Corrigan and Dr Stephen Finn
Part 2: How to get biopsies for testing? ( Dr Lynda Corrigan and Dr Stephen Finn )
5 May 2026

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing

Prof Eva Compérat - Medical University of Vienna, Vienna, Austria
Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing ( Prof Eva Compérat - Medical University of Vienna, Vienna, Austria )
5 May 2026